 IRVINE, Calif., July 27, 2022 GLOBE NEWSWIRE -- Oncocyte Corporation Nasdaq: OCX, a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey, announced today that it will release its second quarter 2022 financial results on Wednesday, August 10, 2022. In conjunction with the release, Oncocyte will host a conference call and webcast that day at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. 